VioQuest Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VOQP research report →
Price Chart
About the company
VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome.
- CEO
- Mark D. Dacko
- IPO
- 1994
- Employees
- 3
- HQ
- Basking Ridge, NJ, US
Get TickerSpark's AI analysis on VOQP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.72K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1325.43%
- ROIC
- -613.09%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $9.74M
- Net Income
- $-10,891,741-31.7%
- EPS
- $-2.33-12.0%
- OCF Growth
- -9.7%
- FCF Growth
- -9.3%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.34
- RSI (14)
- 100
- Avg Volume
- 82
No earnings-call transcripts are available for VOQP yet.
- Free Float
- 111.3%
- Shares Outstanding
- 4.91M
- Float Shares
- 5.46M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 21, 08 | SCHNITTKER CHRISTOPHER P | other | 180,000 |
| Jul 21, 08 | SCHNITTKER CHRISTOPHER P | other | 0 |
| Jun 13, 08 | WEISER MICHAEL | other | 100,000 |
| Jun 13, 08 | WEISER MICHAEL | other | 10,000 |
| Jun 13, 08 | WEISER MICHAEL | other | 1,290 |
| Jun 13, 08 | WEISER MICHAEL | sell | 10,000 |
| Jun 13, 08 | WEISER MICHAEL | sell | 1,290 |
| Mar 14, 08 | WEISER MICHAEL | other | 10.57 |
| Mar 14, 08 | WEISER MICHAEL | other | 2,631 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VOQP coverage
Recent articles, reports, and earnings notes.
No research on VOQP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VOQP report →